Form 8-K - Current report:
SEC Accession No. 0001493152-26-040577
Filing Date
2026-08-28
Accepted
2026-08-28 16:05:28
Documents
11
Period of Report
2026-08-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41914
  Complete submission text file 0001493152-26-040577.txt   211233

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE juns-20260827.xsd EX-101.SCH 3050
3 XBRL LABEL FILE juns-20260827_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE juns-20260827_pre.xml EX-101.PRE 22382
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3324
Mailing Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477
Business Address 1001 NORTH US HWY 1 SUITE 504 JUPITER FL 33477 (561) 406-6154
JUPITER NEUROSCIENCES, INC. (Filer) CIK: 0001679628 (see all company filings)

EIN.: 474828381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41265 | Film No.: 261339964
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)